FDA seeks more time for vandetanib review

[NewsWhore]

AstraZeneca PLC said the U.S. Food and Drug Administration will take three more months to review the British company's application for vandetanib, a drug it is developing as a treatment for a rar

More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/41841037/)